What is this medicine used for?
FDA-approved uses
- Mild-to-moderate Alzheimer’s dementia — Adults. Symptomatic treatment; not disease modification.Rivastigmine tartrate oral capsules; Exelon Patch transdermal system.
- Severe Alzheimer’s dementia — Adults. Patch-specific indication; do not extend to capsules.Exelon Patch transdermal system.
- Mild-to-moderate Parkinson’s disease dementia — Adults. Dementia symptoms, not a general motor-symptom indication.Rivastigmine tartrate oral capsules; Exelon Patch transdermal system.
What should I expect?
Treatment may help thinking or everyday functioning, or make decline less noticeable for a time. It does not cure dementia or reverse the underlying disease.
Dose increases occur gradually over weeks to limit stomach effects. A caregiver can help track practical benefit, weight, appetite and falls; persistent vomiting, fainting or a significant patch reaction needs earlier contact.
How do I take it safely?
Take capsules with morning and evening meals. Replace the patch every 24 hours and remove the old patch first. Never wear more than one or cut a patch.
Apply the patch to clean, dry, intact skin on the upper or lower back, upper arm or chest. Rotate sites; avoid the same exact spot for at least 14 days. Avoid prolonged external heat and excessive sunlight, wash hands after handling, and keep used patches from children and pets.
Follow weight, appetite, hydration, pulse, fainting, tremor and skin changes. Low body weight and kidney or liver disease can affect tolerability. A caregiver’s administration record can help prevent duplicate doses.
Have beta blockers, metoclopramide, other dementia medicines, medicines with anticholinergic effects and anti-inflammatory pain medicines reviewed. Tell the anesthesia team before surgery.
After more than three days without treatment, contact the prescriber before restarting: a low restart dose and gradual increases are required. Do not double oral doses. If a patch falls off or is missed, ensure no old patch remains, apply a new one and resume the usual change time the following day.
Do not use after a serious rivastigmine allergy or a patch reaction suggesting allergic contact dermatitis. Discuss heart-conduction problems, ulcers, seizures, urinary blockage or lung disease. Pregnancy and breastfeeding evidence is limited; pediatric use is not established.
What side effects should I know about?
- Nausea, vomiting, diarrhea, appetite or weight loss and dizziness.
- Patch-site irritation; tremor can worsen.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Exelon Patch: current prescribing information
- View FDA Prescribing Information (PDF) (opens in a new tab)Rivastigmine tartrate capsules: current generic labeling
Which warning signs need help?
- Multiple patches can cause overdose: remove all patches and obtain immediate poison-center or emergency advice.
- Persistent or severe vomiting or diarrhea can cause dangerous dehydration. Contact the clinician promptly, especially with poor intake or weight loss.
- Fainting or a very slow pulse needs urgent assessment. Black stools, vomiting blood, seizure or breathing difficulty needs urgent care.
- A patch rash spreading beyond the patch, with swelling or blisters, or not improving within 48 hours after removal can be an allergy. Stop use and contact the clinician promptly; widespread rash or breathing symptoms needs urgent care.
- Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.
What else should I know to stay safe?
- Remove the old patch before applying another; never wear multiple patches or cut a patch. Avoid prolonged external heat, and keep used patches away from children and pets. After more than three days without rivastigmine, contact the prescriber before restarting: a low restart dose and gradual increases are required.
- Do not use after serious rivastigmine allergy or a patch reaction suggesting allergic contact dermatitis. Low weight, kidney or liver disease, heart-conduction problems, ulcers, seizures, urinary blockage and lung disease need assessment. Monitor weight, appetite, hydration, pulse, tremor and skin reactions.
- Review beta blockers, metoclopramide, other dementia medicines, anticholinergic medicines and anti-inflammatory pain medicines; tell the anesthesia team before surgery. Pregnancy and breastfeeding evidence is limited. The selected oral rivastigmine and Exelon patch labels do not recommend use below age 18 because pediatric safety and effectiveness have not been established.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- The most important patch check is whether yesterday’s patch has been removed. Multiple patches can cause a dangerous overdose.
- A patch still delivers a medicine throughout the body. Nausea, low pulse and weight loss can occur even without swallowing a tablet.
- After a treatment interruption, the old maintenance dose may be too much. Restart instructions are part of safe dementia care.
How does it work?
Rivastigmine slows the breakdown of acetylcholine, a chemical messenger used by brain cells. This can support communication in networks involved in memory and thinking by making more of the remaining messenger available. Its purpose is to help with symptoms; it has not been shown to stop the underlying disease process.
Explore more in Brain & Science: Acetylcholine Breakdown: Donepezil.
How was this medicine developed?
Exelon capsules received FDA approval in 2000, followed by the patch in 2007. The patch introduced another way to deliver the medicine, with different handling instructions and a later severe-Alzheimer’s indication. Neither form has been shown to reverse the underlying disease.
How do I say the name?
Rivastigmine: ri-va-STIG-meen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Rivastigmine tartrate capsules
Twice daily with meals; dementia-specific titration intervals.
Rivastigmine daily patch
Only one patch at a time; replace every 24 hours.
Rivastigmine oral solution
Product-specific measuring and handling instructions are outside this capsule-and-patch article.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Exelon Patch: current prescribing information
- Rivastigmine tartrate capsules: current generic labeling
- Exelon capsules: FDA approval and discontinued brand status
- Rivastigmine oral: patient information and historical brand status
- Exelon Patch: FDA approval and product status
- Exelon Patch: FDA prescribing information
- Exelon Patch: Package Insert / Prescribing Information / MOA
- Exelon capsules and oral solution: FDA labeling
- Rivastigmine patch: patient information
- Galantamine: current tablet prescribing information
- Rivastigmine: verified neutral parent, PubChem CID 77991
- Rivastigmine Sandoz 2 mg/ml oral solution: Summary of Product Characteristics — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: 5.1 Pharmacodynamic properties..
Giving medicine safely to children: family guide (PDF, 3 pages)

